Cargando…
Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting
OBJECTIVE: This prospective study aimed to investigate the effects of the selective angiotensin receptor antagonist, telmisartan, on microalbuminuria after coronary artery bypass surgery in patients with diabetes mellitus. METHODS: Patients were divided into two groups with block randomisation, usin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558141/ https://www.ncbi.nlm.nih.gov/pubmed/27834982 http://dx.doi.org/10.5830/CVJA-2016-089 |
_version_ | 1783257346597715968 |
---|---|
author | Furat, Cevdet Dogan, Riza Ilhan, Gokhan Bayar, Ekrem Ozpak, Berkan Kara, Hakan Bozok, Şahin |
author_facet | Furat, Cevdet Dogan, Riza Ilhan, Gokhan Bayar, Ekrem Ozpak, Berkan Kara, Hakan Bozok, Şahin |
author_sort | Furat, Cevdet |
collection | PubMed |
description | OBJECTIVE: This prospective study aimed to investigate the effects of the selective angiotensin receptor antagonist, telmisartan, on microalbuminuria after coronary artery bypass surgery in patients with diabetes mellitus. METHODS: Patients were divided into two groups with block randomisation, using the sealed envelope technique: group T (telmisartan group) consisted of patients who received the angiotensin receptor blocking agent telmisartan 80 mg daily for at least six months in the pre-operative period; group N-T (non-telmisartan group) consisted of patients who received no telmisartan treatment. Clinical and demographic characteristics, operative and postoperative features, microalbuminuria and high-sensitivity C-reactive protein levels were compared. RESULTS: Forty patients met the eligibility criteria for the study. The groups did not differ with regard to clinical and demographic characteristics, and operative and postoperative features. Microalbuminuria levels between the groups differed significantly in the pre-operative period, first hour postoperatively and fifth day postoperatively. C-reactive protein levels between the groups differed significantly on the fifth day postoperatively. CONCLUSION: Telmisartan was useful for decreasing systemic inflammation and levels of urinary albumin excretion in patients who had type 2 diabetes mellitus and had undergone coronary artery bypass surgery. |
format | Online Article Text |
id | pubmed-5558141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Clinics Cardive Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-55581412017-08-30 Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting Furat, Cevdet Dogan, Riza Ilhan, Gokhan Bayar, Ekrem Ozpak, Berkan Kara, Hakan Bozok, Şahin Cardiovasc J Afr Cardiovascular Topics OBJECTIVE: This prospective study aimed to investigate the effects of the selective angiotensin receptor antagonist, telmisartan, on microalbuminuria after coronary artery bypass surgery in patients with diabetes mellitus. METHODS: Patients were divided into two groups with block randomisation, using the sealed envelope technique: group T (telmisartan group) consisted of patients who received the angiotensin receptor blocking agent telmisartan 80 mg daily for at least six months in the pre-operative period; group N-T (non-telmisartan group) consisted of patients who received no telmisartan treatment. Clinical and demographic characteristics, operative and postoperative features, microalbuminuria and high-sensitivity C-reactive protein levels were compared. RESULTS: Forty patients met the eligibility criteria for the study. The groups did not differ with regard to clinical and demographic characteristics, and operative and postoperative features. Microalbuminuria levels between the groups differed significantly in the pre-operative period, first hour postoperatively and fifth day postoperatively. C-reactive protein levels between the groups differed significantly on the fifth day postoperatively. CONCLUSION: Telmisartan was useful for decreasing systemic inflammation and levels of urinary albumin excretion in patients who had type 2 diabetes mellitus and had undergone coronary artery bypass surgery. Clinics Cardive Publishing 2017 /pmc/articles/PMC5558141/ /pubmed/27834982 http://dx.doi.org/10.5830/CVJA-2016-089 Text en Copyright © 2015 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cardiovascular Topics Furat, Cevdet Dogan, Riza Ilhan, Gokhan Bayar, Ekrem Ozpak, Berkan Kara, Hakan Bozok, Şahin Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting |
title | Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting |
title_full | Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting |
title_fullStr | Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting |
title_full_unstemmed | Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting |
title_short | Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting |
title_sort | telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting |
topic | Cardiovascular Topics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558141/ https://www.ncbi.nlm.nih.gov/pubmed/27834982 http://dx.doi.org/10.5830/CVJA-2016-089 |
work_keys_str_mv | AT furatcevdet telmisartandecreasesmicroalbuminuriainpatientswithtype2diabetesmellitusfollowingcoronaryarterybypassgrafting AT doganriza telmisartandecreasesmicroalbuminuriainpatientswithtype2diabetesmellitusfollowingcoronaryarterybypassgrafting AT ilhangokhan telmisartandecreasesmicroalbuminuriainpatientswithtype2diabetesmellitusfollowingcoronaryarterybypassgrafting AT bayarekrem telmisartandecreasesmicroalbuminuriainpatientswithtype2diabetesmellitusfollowingcoronaryarterybypassgrafting AT telmisartandecreasesmicroalbuminuriainpatientswithtype2diabetesmellitusfollowingcoronaryarterybypassgrafting AT ozpakberkan telmisartandecreasesmicroalbuminuriainpatientswithtype2diabetesmellitusfollowingcoronaryarterybypassgrafting AT karahakan telmisartandecreasesmicroalbuminuriainpatientswithtype2diabetesmellitusfollowingcoronaryarterybypassgrafting AT bozoksahin telmisartandecreasesmicroalbuminuriainpatientswithtype2diabetesmellitusfollowingcoronaryarterybypassgrafting |